Viral gastroenteritis global market report 2023: market size will reach US$7.68 billion by 2027

Global viral gastroenteritis market

Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) — The “Viral Gastroenteritis Global Market Report 2023” report has been added to ResearchAndMarkets.com Dedication.

The global viral gastroenteritis market is expected to grow from US$5.99 billion in 2022 to US$6.34 billion in 2023, at a compound annual growth rate (CAGR) of 6%. The viral gastroenteritis market is expected to reach US$7.68 billion by 2027, growing at a CAGR of 4.9%.

In the treatment of viral gastroenteritis, various types of drugs are used, including antibiotics, antacids, laxatives, antiperistaltic agents, etc. Antacids play a vital role in neutralizing stomach acid to relieve heartburn and indigestion.

Diagnosis of viral gastroenteritis involves a physical examination and a rapid stool test, guided by symptoms such as watery diarrhea, abdominal cramping, and pain. This condition can be caused by different viruses, including norovirus, rotavirus, astrovirus, and enteric adenovirus. These treatments are used in a variety of healthcare settings, including hospitals, clinics, pharmaceutical companies, diagnostic centers, and ambulatory care centers.

The Viral Gastroenteritis market research report provides statistical data on the Viral Gastroenteritis market including global market size, regional shares, competitive insights of market share data, detailed segments, trends, opportunities, and insights into the Viral Gastroenteritis market. Additional information critical to success in the industry.

A notable trend in the viral gastroenteritis market is product innovation, with major companies focusing on developing new products to consolidate their market positions. For example, GlaxoSmithKline plc received FDA approval in November 2022 to launch ROTARIX (an infant rotavirus gastroenteritis vaccine) for oral administration only. This innovation eliminates the need for vaccine recombination, makes it more convenient for healthcare providers, and improves safety and immunogenicity.

The story continues

In March 2021, Hologic, Inc. acquired Diagenode for $159 million, expanding its diagnostics business and products that detect bacteria, parasites and viruses associated with a variety of infections, including gastroenteritis. The increasing prevalence of gastrointestinal diseases is expected to drive the growth of the viral gastroenteritis market. Gastrointestinal diseases affect the digestive tract, and treatment of viral gastroenteritis is critical with proper medication use.

In the highly competitive healthcare space, staying up to date with the latest market insights is crucial. The viral gastroenteritis market, represented by industry leaders such as Pfizer and Sanofi, requires the latest knowledge to navigate effectively.

North America will lead the viral gastroenteritis market in 2022, with Asia Pacific expected to be the fastest growing region. This growth is attributed to the rising prevalence of gastrointestinal diseases and increasing market products, including diagnostics and various drug types.

Countries covered in the viral gastroenteritis market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom, United States, Canada, Italy, and Spain.

Key attributes:

The major players in the viral gastroenteritis market are

• Pfizer

• AbbVie

• Bayer AG

• Sanofi

• AstraZeneca

• Abbott Laboratories

• GSK

• Takeda Pharmaceutical Co., Ltd.

• Eli Lilly and Company

• Amgen

• CH Boehringer Sohn AG & Co. KG

• Daiichi Sankyo Co., Ltd.

• Regeneron Pharmaceuticals

• Mylan Corporation

• Astellas Pharmaceuticals

• Fresenius Kabi AG

• Dr. Health, Inc.

• Alexion Pharmaceuticals

• Horizon Therapeutics

• Dr. Reddy’s Laboratories Ltd.

• BioMarin Pharmaceuticals

• Lupine Ltd.

• Zydus Life Sciences Ltd.

• Alken Laboratories Ltd.

• Ironwood Pharmaceuticals

• Ani Pharmaceuticals

• Merck Sharp & Dohme

• Allergan

• Haustus Biotech Pty Ltd

• Grace Life Sciences India Pvt Ltd

Key topics covered:

1.executive Summary

2. Viral gastroenteritis market characteristics

3. Viral Gastroenteritis Market Trends and Strategies

4. Viral Gastroenteritis Market – Macroeconomic Scenario
4.1. The impact of high inflation on the online therapy service market
4.2. Impact of the Ukraine-Russia War on the Online Therapy Services Market
4.3. Impact of COVID-19 on the Online Therapy Services Market
5.1. Global viral gastroenteritis historical market size and growth, 2017 – 2022, value (USD billion)
5.2. Global Viral Gastroenteritis Forecast Market Size and Growth, 2022 – 2027, 2032F, Value (USD Billion)
5.3. Global Viral Gastroenteritis Market Drivers and Restraints
5.3.1. Market drivers
5.3.2. Market restrictions

6. Viral Gastroenteritis Market Segmentation
6.1. Global Viral Gastroenteritis Market, Segmentation by Drug, History and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

• antibiotic

• Antacids

• laxative

• antikinesis agent

• other drugs

6.2. Global Viral Gastroenteritis Market, Segmented by Diagnosis, Historical and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

• Physical examination

• rapid stool test

6.3. Global Viral Gastroenteritis Market, Segmented by Indication, Historical and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

• watery diarrhea

• Vomit

• abdominal cramps

• pain

• Other indications

6.4. Global Viral Gastroenteritis Market, Segmentation by Virus Type, History and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

• norovirus

• rotavirus

• Astrovirus

• enteric adenovirus

6.5. Global Viral Gastroenteritis Market, Segmented by End User, History and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

• Hospital

• Clinic

• pharmaceutical company

• diagnostic center

• Ambulatory Care Center

• other end users

7. Viral Gastroenteritis Market Regional and Country Analysis
7.1. Global Viral Gastroenteritis Market, by Region, History and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion
7.2. Global Viral Gastroenteritis Market, by Country, Historical and Forecast, 2017-2022, 2022-2027F, 2032F, USD Billion

For more information about this report, please visit https://www.researchandmarkets.com/r/kdgfpe

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900